Werbung
Vertex Pharmaceuticals Umsatz, Kennzahlen, Bilanz/GuV
Um die angezeigten Werte im Chart zu ändern, klicken Sie bitte unten in der Tabelle die entsprechenden Werte an (max. 4 gleichzeitig)
Vertex Pharmaceuticals: Die Aktie (in ARS)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| 1.927.090,33 | -192.364,92 | 413.051,75 | 169.315,82 | 86.644,74 | 73.462,08 | 21.990,27 | |
| 1.944.739,81 | -192.066,20 | 417.684,53 | 171.316,70 | 87.399,35 | 74.502,90 | 22.350,50 | |
| 1.927.402,29 | -192.066,20 | 413.195,09 | 169.332,99 | 86.659,55 | 73.497,34 | 22.012,26 | |
| 0,000 | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | |
| 0,000 | 0,000 | 0,000 | 0,000 | 0,000 | 0,000 | 0,000 |
Vertex Pharmaceuticals: Unternehmenskennzahlen (in ARS)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| 5.887.031,42 | 3.939.014,17 | 1.123.169,90 | 445.923,95 | 281.368,89 | 168.301,53 | 77.256,84 | |
| 0,004 | - | - | - | - | - | - | |
| 0,004 | - | - | - | - | - | - | |
| 0,000 | - | - | - | - | - | - | |
| 71,40 | 71,07 | 76,15 | 76,65 | 75,19 | 73,92 | 73,15 | |
| 28,60 | 28,93 | 23,85 | 23,35 | 24,81 | 26,08 | 26,85 |
Vertex Pharmaceuticals: GuV (in Mio. ARS)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| 15.038.159,47 | 10.058.136,18 | 2.896.888,71 | 1.143.949,47 | 724.037,37 | 438.910,40 | 199.393,78 | |
| 49,51 | 247,20 | 153,24 | 58,00 | 64,96 | 120,12 | 132,63 | |
| 12.787.529,39 | 8.656.696,19 | 2.525.260,20 | 1.002.685,14 | 637.945,82 | 386.865,13 | 172.950,13 | |
| 47,72 | 242,80 | 151,85 | 57,17 | 64,90 | 123,69 | 133,09 | |
| 5.929.154,24 | 3.991.700,33 | 1.259.361,93 | 546.972,66 | 267.453,18 | 203.084,97 | 56.457,95 | |
| 48,54 | 216,96 | 130,24 | 104,51 | 31,70 | 259,71 | 201,90 | |
| 5.782.815,34 | 227.545,14 | 1.289.540,93 | 553.445,48 | 259.969,44 | 220.310,45 | 67.341,32 | |
| 2.441,39 | -82,35 | 133,00 | 112,89 | 18,00 | 227,15 | 299,08 | |
| 4.923.463,47 | -490.435,32 | 1.065.715,86 | 434.397,95 | 222.998,25 | 191.672,41 | 56.811,86 | |
| - | - | 145,33 | 94,80 | 16,34 | 237,38 | -3,60 |
Vertex Pharmaceuticals: Bilanz (in Mio. ARS)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| 10.853.258,80 | 6.888.111,00 | 4.451.498,13 | 750.646,68 | 342.220,09 | 257.674,58 | 133.709,42 | |
| 2.087.083,58 | 1.262.992,78 | 620.606,70 | 104.131,79 | 48.521,49 | 38.796,53 | 20.976,38 | |
| 27.094.390,54 | 16.918.297,60 | 14.213.683,09 | 2.464.140,91 | 1.037.186,18 | 730.302,28 | 364.341,21 | |
| 60,15 | 19,03 | 476,82 | 137,58 | 42,02 | 100,44 | 118,13 | |
| 37.947.649,33 | 23.806.408,60 | 18.665.181,23 | 3.214.787,59 | 1.379.406,27 | 987.976,85 | 498.050,63 | |
| 59,40 | 27,54 | 480,60 | 133,06 | 39,62 | 98,37 | 111,74 |
Vertex Pharmaceuticals: sonstige Angaben (in ARS)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| - | -145,98 | 143,81 | 96,02 | 17,31 | 233,34 | -4,47 | |
| - | -146,48 | 144,01 | 95,40 | 17,91 | 233,89 | -4,17 | |
| 6.400,00 | 6.100,00 | 5.400,00 | 4.800,00 | 3.900,00 | 3.400,00 | 3.000,00 | |
| 4,92 | 12,96 | 12,50 | 23,08 | 14,71 | 13,33 | 20,00 |
Die Daten werden von FactSet zur Verfügung gestellt.
FactSet vereinheitlicht die Rechnungslegungsstandards IFRS und US-GAAP, um Unternehmenszahlen branchen- und länderübergreifend vergleichbar zu machen.